No need to tax the sick: Clinical guidelines for rofecoxib as an alternative effective method to the copayment policy in the advent of increasing pharmaceutical expenditures

Yitzhak Rosen, Naomi Yachelevich, Paul Benedek, Itamar Grotto, Avishy Goldberg, Yair Morad, Hadar Marom, Nissim Ohana, Yaron Bar-Dayan

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'No need to tax the sick: Clinical guidelines for rofecoxib as an alternative effective method to the copayment policy in the advent of increasing pharmaceutical expenditures'. Together they form a unique fingerprint.

Medicine & Life Sciences